קפרה תמיסה לבליעה ישראל - עברית - Ministry of Health

קפרה תמיסה לבליעה

cts ltd - levetiracetam - תמיסה - levetiracetam 100 mg/ml - levetiracetam - levetiracetam - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. keppra is indicated as adjunctive therapy - in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לוותרים תמיסה ישראל - עברית - Ministry of Health

לוותרים תמיסה

trima israel pharmaceutical products maabarot ltd - levetiracetam - תמיסה (פומי) - levetiracetam 100 mg/ml - levetiracetam - levetiracetam - levetrim solution is indicated as:- monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. - adjunctive therapy:in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy

לבטיראצטם טבע ® 250 מ"ג ישראל - עברית - Ministry of Health

לבטיראצטם טבע ® 250 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 250 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם טבע ® 500 מ"ג ישראל - עברית - Ministry of Health

לבטיראצטם טבע ® 500 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 500 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם טבע ® 1000 מ"ג ישראל - עברית - Ministry of Health

לבטיראצטם טבע ® 1000 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 1000 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם אלטן 100 מגמל ישראל - עברית - Ministry of Health

לבטיראצטם אלטן 100 מגמל

propharm ltd - levetiracetam - תרכיז להכנת תמיסה לאינפוזיה - levetiracetam 100 mg / 1 ml - levetiracetam

לוובון  100 מגמל ישראל - עברית - Ministry of Health

לוובון 100 מגמל

a.l. medi-market ltd. - levetiracetam - תרכיז להכנת תמיסה לאינפוזיה - levetiracetam 100 mg / 1 ml - levetiracetam